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Examination of NADH pharmacokinetic in vivo and in vitro 
 
NADH is one of the most important coenzymes of the intermediary metabolism. During the 
processes ranging from digestion to the eventual synthesis of ATP, it is in charge of 
capturing free electrons and transporting them to the site of reaction. The critical role of 
NADH as the primary source of reducing equivalents is most prominent in the Krebs cycle 
and in oxidative phosphorylation.  
 
In light of the central role of NADH within energy metabolism, in recent decades many 
research approaches have emerged examining its influence on pathogenic and symptomatic 
parameters (Mitochondrial diseases: Alzheimer’s disease, Parkinson’s disease) as well as its 
use as a diagnostic tool (tumor diagnosis).   
 
The present study aims at analyzing certain aspects of NADH pharmacokinetic.  First, we 
investigated whether NADH is indeed absorbed by the intestine. In a second step we 
focused on the question whether sublingually administered NADH is able to influence NADH 
concentration within the cerebral cortex of the rat.   
In addition, changes in cortical NADH fluorescence were examined prior to administration of 
the  oxidized analogue NAD+.   
 
The preliminary experiment was undertaken in vitro using the everted gut sack model.  
The absorption rate of NADH was compared to Diazepam, a substance that is absorbed well 
through the intestinal wall, and Strophantine, known to be poorly absorbed by the intestine.  
The data obtained for NADH was in all cases below the Strophantine absorption rate. 
Statistical analysis of the absorption rates of the three NADH doses (NADH 10, 50 and 
100mg/kg) studied revealed no significant differences. 
 
NADH/NAD+ redox-system is endowed with properties ideally suited for spectroscopic 
detection, such as laser-induced fluorescence spectroscopy. Only the reduced form NADH 
reacts to radiation (λ = 340nm) with the emission of a characteristic fluorescence spectrum  
(maximum at λ = 464nm). The signal emitted is proportional to intracellular NADH 
concentration.  
 
Employing a laser-induced fluorescence spectroscopic detection technique, we studied the 
central bioavailability of NADH in the cortex of anaesthetized rats following sublingual 
administration of three different NADH dosages (10mg/kg, 50mg/kg and 100mg/kg).  





The data collected revealed that central bioavailabiliy of NADH was only considerably 
influenced by a dose of NADH 100mg/kg, showing a significant increase in cortical NADH 
fluorescent signal.    
 
 
The fact that the administration of NAD+, a non-fluorescent compound, also induces a rise in 
cortical NADH fluorescence, is consistent with the notion that there is an equilibrium  
between the low-energy form NAD+ and the high-energy form NADH. 
 
On the basis of the data obtained, we conclude that absorption and central bioavailability of 




        
 
 
